RIGL - Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call Transcript
2025-08-05 20:02:09 ET
Rigel Pharmaceuticals, Inc. (RIGL)
Q2 2025 Earnings Conference Call
August 05, 2025, 04:30 PM ET
Company Participants
David A. Santos - Executive VP & Chief Commercial Officer
Dean L. Schorno - Executive VP & CFO
Lisa Rojkjaer - Executive VP & Chief Medical Officer
Raul R. Rodriguez - President, CEO & Director
Raymond J. Furey - Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary
Conference Call Participants
Joseph Pantginis - H.C. Wainwright & Co, LLC, Research Division
Yigal Dov Nochomovitz - Citigroup Inc., Research Division
Presentation
Operator
Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the Second Quarter 2025. [Operator Instructions] As a reminder, this conference is being recorded....
Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call Transcript